Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations (Q27853094)

PubMed publication ID

25412851

13 November 2016

title

Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations (English)

1 reference

PubMed publication ID

13 November 2016

1 reference

acute myeloid leukemia

1 reference

Robert S Ohgami

1

0 references

Lisa Ma

2

0 references

Jason D Merker

3

0 references

Jason R Gotlib

4

0 references

Iris Schrijver

5

0 references

James L Zehnder

6

0 references

Daniel A Arber

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

7

0 references

language of work or name

1 reference

May 2015

0 references

published in

Modern Pathology

0 references

volume

28

0 references

issue

5

0 references

page(s)

706-14

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

DNMT3A Mutations in Acute Myeloid Leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

Genome regulation by polycomb and trithorax proteins

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

Polycomb silencing mechanisms and the management of genomic programmes

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2014.160

The origin and evolution of mutations in acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

21 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Splicing factor mutations and cancer

26 May 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Clinical and biological implications of driver mutations in myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

29 September 2017

p53 mutations in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Incidence, survival and prevalence of myeloid malignancies in Europe.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Genetic and epigenetic complexity in myeloproliferative neoplasms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Alternative epigenetic chromatin states of polycomb target genes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Biochemical mechanisms of gene regulation by polycomb group protein complexes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Acute myeloid leukemia: epidemiology and etiology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5436901

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

29 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

The p53 family in differentiation and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

Chromatin: TET2 keeps histones sweet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.160

Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies

21 January 2018

1 reference

12 December 2020

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

1 reference

12 December 2020

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

1 reference

12 December 2020

DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups

1 reference

12 December 2020

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

1 reference

12 December 2020

10.1038/MODPATHOL.2014.160

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1027329090

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

PMC publication ID

5436901

0 references

PubMed publication ID

25412851

1 reference

Consolidated OpenCitations Corpus – April 2017